| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0000796848-22-000001 | Dec 31st, 2021 12:00AM | Feb 10th, 2022 12:00AM | Feb 10th, 2022 12:00AM | TEACHER RETIREMENT SYSTEM OF TEXAS | 796848 | LIGAND PHARMACEUTICALS INC | COM NEW | 53220K504 | 506 | 3276 | SH | SOLE | 3276 | 0 | 0 | May 6th, 2022 08:35AM | May 6th, 2022 08:35AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0000019617-22-000233 | Dec 31st, 2021 12:00AM | Feb 10th, 2022 12:00AM | Feb 10th, 2022 12:00AM | JPMORGAN CHASE & CO | 19617 | LIGAND PHARMACEUTICALS INC | COMMON | 53220K504 | 7 | 47 | SH | DFND | 1 | 0 | 0 | 47 | May 6th, 2022 08:34AM | May 6th, 2022 08:34AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0000019617-22-000233 | Dec 31st, 2021 12:00AM | Feb 10th, 2022 12:00AM | Feb 10th, 2022 12:00AM | JPMORGAN CHASE & CO | 19617 | LIGAND PHARMACEUTICALS INC | COMMON | 53220K504 | 4986 | 32282 | SH | DFND | 4 | 30160 | 0 | 2122 | May 6th, 2022 08:34AM | May 6th, 2022 08:34AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0000019617-22-000233 | Dec 31st, 2021 12:00AM | Feb 10th, 2022 12:00AM | Feb 10th, 2022 12:00AM | JPMORGAN CHASE & CO | 19617 | LIGAND PHARMACEUTICALS INC | COMMON | 53220K504 | 938 | 6071 | SH | DFND | 2 | 6043 | 0 | 28 | May 6th, 2022 08:34AM | May 6th, 2022 08:34AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0000019617-22-000233 | Dec 31st, 2021 12:00AM | Feb 10th, 2022 12:00AM | Feb 10th, 2022 12:00AM | JPMORGAN CHASE & CO | 19617 | LIGAND PHARMACEUTICALS INC | COMMON | 53220K504 | 233 | 1506 | SH | DFND | 6 | 1506 | 0 | 0 | May 6th, 2022 08:34AM | May 6th, 2022 08:34AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0000019617-22-000233 | Dec 31st, 2021 12:00AM | Feb 10th, 2022 12:00AM | Feb 10th, 2022 12:00AM | JPMORGAN CHASE & CO | 19617 | LIGAND PHARMACEUTICALS INC | COMMON | 53220K504 | 3 | 17 | SH | OTR | 1 | 0 | 0 | 17 | May 6th, 2022 08:34AM | May 6th, 2022 08:34AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0001648711-22-000002 | Dec 31st, 2021 12:00AM | Feb 9th, 2022 12:00AM | Feb 9th, 2022 12:00AM | Baird Financial Group, Inc. | 1648711 | LIGAND PHARMACEUTICALS | COMMON | 53220K504 | 545 | 3527 | SH | DFND | 1 | 3527 | 0 | 0 | May 6th, 2022 08:29AM | May 6th, 2022 08:29AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0001398344-22-002508 | Dec 31st, 2021 12:00AM | Feb 9th, 2022 12:00AM | Feb 9th, 2022 12:00AM | ALPS ADVISORS INC | 1376113 | LIGAND PHARMACEUTICALS INC | COM NEW | 53220K504 | 2987 | 19340 | SH | DFND | 19340 | 0 | 0 | May 6th, 2022 08:28AM | May 6th, 2022 08:28AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0001207017-22-000002 | Dec 31st, 2021 12:00AM | Feb 9th, 2022 12:00AM | Feb 9th, 2022 12:00AM | LAZARD ASSET MANAGEMENT LLC | 1207017 | LIGAND PHARMACE | Common Stock | 53220K504 | 133 | 867 | SH | SOLE | 867 | 0 | 0 | May 6th, 2022 08:28AM | May 6th, 2022 08:28AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:lgnd | nasdaq:lgnd Shareholders | 13F-HR | 0001166588-22-000005 | Dec 31st, 2021 12:00AM | Feb 9th, 2022 12:00AM | Feb 9th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | LIGAND PHARMACEUTICALS INC | EQUITY | 53220K504 | 1576573 | 10207 | SH | DFND | 1 | 0 | 10207 | 0 | May 6th, 2022 08:28AM | May 6th, 2022 08:28AM | Ligand Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology |